Singular Genomics Systems Inc (OMIC) Return on Assets ROA from the third quarter of 2024 to third quarter of 2023 and for the year 2024, Average High and Low, Fundamental Ratios from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Singular Genomics Systems Inc   (NASDAQ: OMIC)


Singular Genomics Systems Inc 's ROA from the third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Singular Genomics Systems Inc 's ROA in the third quarter of 2024?
Singular Genomics Systems Inc recorded a cumulative net loss of $-86 million during 12 months ending in the third quarter of 2024, resulting in a negative return on assets (ROA) of -37.9%.

However, within the Healthcare sector 524 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2024 from 4060 to 4075.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Total Assets Change -34.36 % -22.31 % -21.54 % -18.87 % -17.55 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -86 -92 -96 -95 -93
Return On Assets (TTM) -37.9 % -36.43 % -35.9 % -33.34 % -30.91 %
OMIC's Total Ranking # 4075 # 4060 # 4105 # 4672 # 4123
Total Assets (TTM) in million 187 220 239 265 284
Seq. Total Assets Change -15.21 % -7.99 % -9.93 % -6.6 % 0.37 %
Seq. Net Income Change - - - - -

OMIC's 5 Years Annual ROA >> Back to OMIC Management Effectiveness >> Compare OMIC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 24
Sector # 525
Overall # 4001

Return On Assets Statistics
High Average Low
-23.24 %
-30.66 %
-37.9 %
  (Sep 30 2024)





Financial Statements
Singular Genomics Systems Inc 's Assets $ 187 million OMIC's Balance sheet
Singular Genomics Systems Inc 's Income $ -17 million Quarterly OMIC's Income Statement
OMIC's Income by Division See OMIC's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
FY
FY
Y / Y Total Assets Change -18.87 % -7.99 % - - -
Total Assets in million 265 327 356 0 0
Y / Y Net Income Change - - - - -
Net Income in million -95 91 -99 0 0
Annual Return On Assets -35.72 % 27.77 % -27.77 % - -

OMIC's 5 Years Annual ROA >> Back to OMIC Management Effectiveness >> Compare OMIC ROA to its Competitors



More Return On Assets Ratios
OMIC's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OMIC's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for OMIC's Competitors
Subscribers only: Roa for Singular Genomics Systems Inc 's Suppliers
Subscribers only: Return On Assets for OMIC's Customers

You may also want to know
OMIC's Roi OMIC's Inventory Turnover Ratio OMIC's Growth Rates OMIC's Dividend Comparisons
OMIC's Profitability Ratios OMIC's Asset Turnover Ratio OMIC's Dividend Growth
OMIC's Roe OMIC's Valuation Ratios OMIC's Financial Strength Ratios OMIC's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2024, within Healthcare Sector ROA

Date modified: 2026-09-08T15:11:23+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.